Linked Life Data

58143

Source:http://linkedlifedata.com/resource/pubmed/id/58143

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:58143rdf:typepubmed:Citationlld:pubmed
pubmed-article:58143lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:58143lifeskim:mentionsumls-concept:C0016360lld:lifeskim
pubmed-article:58143lifeskim:mentionsumls-concept:C0038952lld:lifeskim
pubmed-article:58143lifeskim:mentionsumls-concept:C0032790lld:lifeskim
pubmed-article:58143lifeskim:mentionsumls-concept:C1527249lld:lifeskim
pubmed-article:58143lifeskim:mentionsumls-concept:C1272706lld:lifeskim
pubmed-article:58143pubmed:issue7965lld:pubmed
pubmed-article:58143pubmed:dateCreated1976-8-2lld:pubmed
pubmed-article:58143pubmed:abstractText83 patients with colorectal carcinoma of the Dukes' C class were randomised to receive postoperative adjuvant therapy with B.C.G. alone or in combination with oral doses of 5-fluorouracil (5-F.U.), and have been followed for up to thirty months. Results were compared with carefully selected historical controls who were treated by surgery alone. A statistically significant prolongation of both disease-free interval and overall survival was observed in 50 patients receiving the combination of B.C.G. and 5-F.U. (P=0.03, P=0.01 respectively) as well as in 33 patients receiving B.C.G. alone (P=0.03, P=0.05 respectively). The efficacy of B.C.G.+5-F.U. was independent of the number of tumour-involved lymph-nodes in the surgical specimen. In contrast, B.C.G. given alone appears to be highly effective among 10 patients with 6 or more positive lymph-nodes (P less than 0.04) and ineffective (as yet) among 23 patients with 5 or less positive lymph-nodes. These results suggest that adjuvant immunotherapy, with or without chemotherapy, can improve the prognosis of surgically treated patients with colorectal carcinoma of the Dukes' C class.lld:pubmed
pubmed-article:58143pubmed:languageenglld:pubmed
pubmed-article:58143pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:58143pubmed:citationSubsetAIMlld:pubmed
pubmed-article:58143pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:58143pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:58143pubmed:statusMEDLINElld:pubmed
pubmed-article:58143pubmed:monthAprlld:pubmed
pubmed-article:58143pubmed:issn0140-6736lld:pubmed
pubmed-article:58143pubmed:authorpubmed-author:HershE MEMlld:pubmed
pubmed-article:58143pubmed:authorpubmed-author:BurgessM AMAlld:pubmed
pubmed-article:58143pubmed:authorpubmed-author:GuttermanJ...lld:pubmed
pubmed-article:58143pubmed:authorpubmed-author:MartinR CRClld:pubmed
pubmed-article:58143pubmed:authorpubmed-author:GehanE AEAlld:pubmed
pubmed-article:58143pubmed:authorpubmed-author:McBrideC MCMlld:pubmed
pubmed-article:58143pubmed:authorpubmed-author:CopelandE MEMlld:pubmed
pubmed-article:58143pubmed:authorpubmed-author:MavligitG MGMlld:pubmed
pubmed-article:58143pubmed:authorpubmed-author:JubertA VAVlld:pubmed
pubmed-article:58143pubmed:authorpubmed-author:SeibertG BGBlld:pubmed
pubmed-article:58143pubmed:authorpubmed-author:SpeerJ FJFlld:pubmed
pubmed-article:58143pubmed:authorpubmed-author:KhankhanianNNlld:pubmed
pubmed-article:58143pubmed:issnTypePrintlld:pubmed
pubmed-article:58143pubmed:day24lld:pubmed
pubmed-article:58143pubmed:volume1lld:pubmed
pubmed-article:58143pubmed:ownerNLMlld:pubmed
pubmed-article:58143pubmed:authorsCompleteYlld:pubmed
pubmed-article:58143pubmed:pagination871-6lld:pubmed
pubmed-article:58143pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:58143pubmed:meshHeadingpubmed-meshheading:58143-Hu...lld:pubmed
pubmed-article:58143pubmed:meshHeadingpubmed-meshheading:58143-Ev...lld:pubmed
pubmed-article:58143pubmed:meshHeadingpubmed-meshheading:58143-Fo...lld:pubmed
pubmed-article:58143pubmed:meshHeadingpubmed-meshheading:58143-Re...lld:pubmed
pubmed-article:58143pubmed:meshHeadingpubmed-meshheading:58143-Co...lld:pubmed
pubmed-article:58143pubmed:meshHeadingpubmed-meshheading:58143-Me...lld:pubmed
pubmed-article:58143pubmed:meshHeadingpubmed-meshheading:58143-Pr...lld:pubmed
pubmed-article:58143pubmed:meshHeadingpubmed-meshheading:58143-BC...lld:pubmed
pubmed-article:58143pubmed:meshHeadingpubmed-meshheading:58143-Po...lld:pubmed
pubmed-article:58143pubmed:meshHeadingpubmed-meshheading:58143-Ti...lld:pubmed
pubmed-article:58143pubmed:meshHeadingpubmed-meshheading:58143-Ly...lld:pubmed
pubmed-article:58143pubmed:meshHeadingpubmed-meshheading:58143-Ne...lld:pubmed
pubmed-article:58143pubmed:meshHeadingpubmed-meshheading:58143-Ad...lld:pubmed
pubmed-article:58143pubmed:meshHeadingpubmed-meshheading:58143-Fl...lld:pubmed
pubmed-article:58143pubmed:year1976lld:pubmed
pubmed-article:58143pubmed:articleTitleProlongation of postoperative disease-free interval and survival in human colorectal cancer by B.C.G. or B.C.G. plus 5-fluorouracil.lld:pubmed
pubmed-article:58143pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:58143pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:58143pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:58143pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:58143pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:58143lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:58143lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:58143lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:58143lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:58143lld:pubmed